Startups
We are Teijin Pharma and our strength is the synergy between our 2 fields of business in pharmaceuticals and home healthcare. Through this synergy, we are able to provide unique and revolutionary solutions on a global scale.
Overview
Location
Japan, Yamaguchi Prefecture, Iwakuni
Employees
51-200
Founded date
1970
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 23, 2025 | Elevara Medicines Raises $70M in Series A Funding | Elevara Medicines, a London, UK-based clinical-stage biotech developing therapies for rheumatoid arthritis (RA) and chronic inflammatory diseases, closed a $70m Series A financing. The round was co-led by Forbion and Sofinnova Partners, wit... |
| Feb 1, 2022 | Anti-Tau Antibody created by Teijin Pharma and developed by Merck & Co., Inc., Kenilworth NJ USA Enters Clinical Development[Teijin Pharma] (PDF: 112.5 KB) | NEWS RELEASE Anti-Tau Antibody created by Teijin Pharma and developed by Merck & Co., Inc., Kenilworth NJ USA Enters Clinical Development Tokyo, Japan, February 1, 2022 --- Teijin Pharma Limited, the core company of the Teijin Group's h... |
Reviews 0
FAQ about TEIJIN PHARMA LIMITED
When was TEIJIN PHARMA LIMITED founded?
TEIJIN PHARMA LIMITED was founded in 1970.
What has the press written about TEIJIN PHARMA LIMITED?
Parsers VC has collected 3 articles mentioning TEIJIN PHARMA LIMITED, among them “Elevara Medicines Raises $70M in Series A Funding” (Oct 23, 2025) and “Anti-Tau Antibody created by Teijin Pharma and developed by Merck & Co., Inc., Kenilworth NJ USA Enters Clinical Development[Teijin Pharma] (PDF: 112.5 KB)” (Feb 1, 2022).
Is TEIJIN PHARMA LIMITED still active?
Yes, TEIJIN PHARMA LIMITED is active; its latest activity on Parsers VC dates from Sep 29, 2026.